Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - AEOLUS PHARMACEUTICALS, INC.exh23_1.htm
S-1 - AEOLUS PHARMACEUTICALS, INC. S-1 - AEOLUS PHARMACEUTICALS, INC.aeoluss1.htm


Exhibit 23.2
 

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the inclusion in this Registration Statement on Form S-1 of Aeolus Pharmaceuticals, Inc. (the “Company”) of our report dated December 20, 2016, relating to our audit of the Company’s consolidated financial statements as of September 30, 2016, and for the year then ended, included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2016. We also consent to the reference to us under the heading “Experts” in this Registration Statement.



HASKELL & WHITE LLP

Irvine, California
December 20, 2016